Cargando…

High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis

BACKGROUND: Studies in patients with decompensated cirrhosis showed a correlation between serum ferritin levels and patients’ prognosis. Besides, red blood cell distribution width (RDW) and mean platelet volume (MPV) have been associated with the severity of hepatic function. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oikonomou, Theodora, Goulis, Ioannis, Soulaidopoulos, Stergios, Karasmani, Areti, Doumtsis, Petros, Tsioni, Konstantina, Mandala, Eudokia, Akriviadis, Evangelos, Cholongitas, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320035/ https://www.ncbi.nlm.nih.gov/pubmed/28243043 http://dx.doi.org/10.20524/aog.2016.0112

Ejemplares similares

Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2017)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia
por: Doumtsis, Petros, et al.
Publicado: (2018)

Pulmonary manifestations of chronic liver disease: a comprehensive review
por: Soulaidopoulos, Stergios, et al.
Publicado: (2020)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2021)

Review article: Update on current and emergent data on hepatopulmonary syndrome
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Tuberculous peritonitis after treatment for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels
por: Sinakos, Emmanouil, et al.
Publicado: (2016)

Everolimus with or without mycophenolate mofetil in a liver transplantation setting: a single-center experience
por: Cholongitas, Εvangelos, et al.
Publicado: (2018)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
por: Tampaki, Maria, et al.
Publicado: (2023)

PB2591: REAL WORLD DATA OF THE MANAGEMENT (TREATMENT AND PREVENTION OF COVID-19 DISEASE) IN PATIENTS WITH HEMATOLOGICAL DISEASES DURING THE PANDEMIC
por: Mparmpouti, Aikaterini, et al.
Publicado: (2023)

Pulmonary function testing in patients with liver cirrhosis (Review)
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Primary Biliary Cirrhosis: Family Stories
por: Smyk, Daniel, et al.
Publicado: (2011)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Serum Ferritin Levels: A Potential Biomarker to Represent Child-Turcotte-Pugh Score among Decompensated Liver Cirrhosis Patients
por: Sungkar, Taufik, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
por: Manolakopoulos, Spilios, et al.
Publicado: (2015)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis
por: McPhail, Mark J.W., et al.
Publicado: (2016)

Treatment of alcoholic hepatitis: is this a “dead-end”?
por: Akriviadis, Evangelos, et al.
Publicado: (2016)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Hepatic Fibrosis Is a Risk Factor for Greater Severity and Worse Outcome of Acute Ischemic Stroke
por: Ztriva, Eleftheria, et al.
Publicado: (2022)

Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
por: Protopapas, Adonis A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j2ih277ploo1i3hr54hjqvufan